116 related articles for article (PubMed ID: 2480377)
1. Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways.
Demotz S; Matricardi PM; Irle C; Panina P; Lanzavecchia A; Corradin G
J Immunol; 1989 Dec; 143(12):3881-6. PubMed ID: 2480377
[TBL] [Abstract][Full Text] [Related]
2. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
[TBL] [Abstract][Full Text] [Related]
3. Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals.
Reijonen H; Elliott JF; van Endert P; Nepom G
J Immunol; 1999 Aug; 163(3):1674-81. PubMed ID: 10415074
[TBL] [Abstract][Full Text] [Related]
4. Delineation of several DR-restricted tetanus toxin T cell epitopes.
Demotz S; Lanzavecchia A; Eisel U; Niemann H; Widmann C; Corradin G
J Immunol; 1989 Jan; 142(2):394-402. PubMed ID: 2463305
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of MHC-antigen complex formation on antigen-presenting cells.
Roosnek E; Demotz S; Corradin G; Lanzavecchia A
J Immunol; 1988 Jun; 140(12):4079-82. PubMed ID: 2453565
[TBL] [Abstract][Full Text] [Related]
6. Peptide-induced T cell clones: specificity, MHC restriction, proliferation and cytokine pattern as a function of different stimulations.
Pichler WJ; Brander C; Mauri D; Frutig K; Wyss-Coray T
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):141-53; discussion 153-4. PubMed ID: 7873053
[TBL] [Abstract][Full Text] [Related]
7. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
[TBL] [Abstract][Full Text] [Related]
8. Identification of two promiscuous T cell epitopes from tetanus toxin.
Ho PC; Mutch DA; Winkel KD; Saul AJ; Jones GL; Doran TJ; Rzepczyk CM
Eur J Immunol; 1990 Mar; 20(3):477-83. PubMed ID: 1690656
[TBL] [Abstract][Full Text] [Related]
9. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
[TBL] [Abstract][Full Text] [Related]
10. Human T cell clones present antigen.
Hewitt CR; Feldmann M
J Immunol; 1989 Jul; 143(2):762-9. PubMed ID: 2472452
[TBL] [Abstract][Full Text] [Related]
11. Distinct protease requirements for antigen presentation in vitro and in vivo.
Matthews SP; Werber I; Deussing J; Peters C; Reinheckel T; Watts C
J Immunol; 2010 Mar; 184(5):2423-31. PubMed ID: 20164435
[TBL] [Abstract][Full Text] [Related]
12. Antigen processing and the human T cell receptor repertoire for insulin.
Miller GG; Hoy JF; Nell LJ; Thomas JW
J Immunol; 1988 Nov; 141(10):3293-8. PubMed ID: 2460529
[TBL] [Abstract][Full Text] [Related]
13. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation.
Hewitt EW; Treumann A; Morrice N; Tatnell PJ; Kay J; Watts C
J Immunol; 1997 Nov; 159(10):4693-9. PubMed ID: 9366392
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability.
Vidard L; Rock KL; Benacerraf B
J Immunol; 1992 Sep; 149(6):1905-11. PubMed ID: 1517561
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
[TBL] [Abstract][Full Text] [Related]
16. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells.
Burster T; Reich M; Zaidi N; Voelter W; Boehm BO; Kalbacher H
Biochem Biophys Res Commun; 2008 Dec; 377(4):1299-303. PubMed ID: 18996084
[TBL] [Abstract][Full Text] [Related]
18. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
19. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
20. Mapping the major human T helper epitopes of tetanus toxin. The emerging picture.
Reece JC; Geysen HM; Rodda SJ
J Immunol; 1993 Dec; 151(11):6175-84. PubMed ID: 7504014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
